RxDoctor Payments Data

Shanti Eppanapally, MD

Anesthesiology · Clifton, NJNPI 1306872635

Payments from drug & device makers

$2,352in general payments, 2019–2025

Across 113 payments — averaging $20.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$456
  • Collegium Pharmaceutical, Inc.$344
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$278
  • Redhill Biopharma Inc.$153
  • Si-bone, Inc.$141
  • GSK$130
  • plus $850 from 19 others

What the payments were for

  • Food & beverage$2,352100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,352 in reported general payments places this provider in the 95th percentile of 1,430 anesthesiology providers in New Jersey.

See all anesthesiology providers in New Jersey

Medicare billing

Part B allowed, 2024
$126,154
Medicare patients
191
Services billed
1,182

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levorphanol Tartrate31$106,832
OxycontinOxycodone Hcl65$50,988
BelbucaBuprenorphine Hcl12$10,035
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen287$6,704
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen200$4,274
Xtampza ErOxycodone Myristate12$4,019
Oxycodone Hcl244$3,852
Hydromorphone ErHydromorphone Hcl12$2,343
Gabapentin169$1,981
Pregabalin93$1,827
Morphine Sulfate ErMorphine Sulfate83$1,596
Cyclobenzaprine Hcl108$1,142
Baclofen56$891
Amitriptyline Hcl28$515
Methocarbamol31$466

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er$344$14,05524 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,430 anesthesiology providers in New Jersey.

Other anesthesiology in Clifton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →